[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336650-105":59,"doc-detail-336650-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","epigenetic-profiling-of-prostate-cancer-reveals-potential-prognostic-signatures","Epigenetic profiling of prostate cancer reveals potential prognostic signatures","","Epigenetic profiling in prostate cancer remains underexplored despite DNA methylation studies in other tumor types. This retrospective study evaluates DNA methylation-based deconvolution of benign and malignant prostate tissues for biomarker discovery and investigates whether radiomics can non-invasively surrogate epigenetic signatures. Thirty prostate cancer patients with preoperative multiparametric MRI were included, with benign-adjacent and benign prostatic hyperplasia controls. Latent methylation components were clustered and linked to cellular composition and clinical parameters; clustering showed prognostic relevance, while radiomics failed to predict clusters.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epigenetic-profiling-of-prostate-cancer-reveals-potential-prognostic-signatures/336650/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epigenetic-profiling-of-prostate-cancer-reveals-potential-prognostic-signatures/336650.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study purpose regarding epigenetic profiling in prostate cancer?","Question",{"text":112,"@type":113},"To discover biomarkers using DNA methylation-based deconvolution in benign versus malignant prostate tissue and to assess whether radiomics can act as a non-invasive surrogate for epigenetic signatures.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients selected and what imaging was used?",{"text":117,"@type":113},"Thirty prostate cancer patients were retrospectively included, all having multiparametric MRI prior to radical prostatectomy between 2014 and 2019. Control tissue came from benign tissue adjacent to tumor lesions and from benign prostatic hyperplasia.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings about latent methylation components and radiomics performance?",{"text":121,"@type":113},"Latent methylation components formed two clusters with prognostic impact; one cluster aligned with malignant tissue and reduced immune-cell-related signatures. No radiomics model could non-invasively predict the epigenetic clusters.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336650,1790153062,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Journal of Cancer Research and Clinical Oncology (2024) 150:396  \n[https://doi.org/10.1007/s00432-024-05921-0](https://doi.org/10.1007/s00432-024-05921-0)  \nRESEARCH  \nEpigenetic profiling of prostate cancer reveals potential prognostic signatures  \nSimon Bernatz1,2,3 · Ian G. Reddin4 · Tim R. Fenton4 · Thomas J. Vogl1 · Peter J. Wild2,5 · Jens Köllermann2 · Philipp Mandel6 · Mike Wenzel6 · Benedikt Hoeh6 · Scherwin Mahmoudi1 · Vitali Koch1 · Leon D. Grünewald1 · Renate Hammerstingl1 · Claudia Döring2 · Patrick N. Harter3,7,8,9,10,11,12 · Katharina J. Weber3,7,8,9,10  \nReceived: 3 July 2024 / Accepted: 11 August 2024 / Published online: 24 August 2024 © The Author(s) 2024  \nAbstract  \nPurpose While epigenetic profiling discovered biomarkers in several tumor entities, its application in prostate cancer is still limited. We explored DNA methylation-based deconvolution of benign and malignant prostate tissue for biomarker discovery and the potential of radiomics as a non-invasive surrogate.  \nMethods We retrospectively included 30 patients (63 [58–79] years) with prostate cancer (PCa) who had a multiparametric MRI of the prostate before radical prostatectomy between 2014 and 2019. The control group comprised four patients with benign prostate tissue adjacent to the PCa lesions and four patients with benign prostatic hyperplasia. Tissue punches of all lesions were obtained. DNA methylation analysis and reference-free in silico deconvolution were conducted to retrieve Latent Methylation Components (LCMs) . LCM-based clustering was analyzed for cellular composition and correlated with clinical disease parameters. Additionally, PCa and adjacent benign lesions were analyzed using radiomics to predict the epigenetic signatures non-invasively.  \nResults LCMs identified two clusters with potential prognostic impact. Cluster one was associated with malignant prostate tissue (p \u003C0.001) and reduced immune-cell-related signatures (p = 0.004) of CD19 and CD4 cells. Cluster one comprised exclusively malignant prostate tissue enriched for significant prostate cancer and advanced tumor stages (p \u003C0.03 for both) . No radiomics model could non-invasively predict the epigenetic clusters.  \nConclusion Epigenetic clusters were associated with prognostically and clinically relevant metrics in prostate cancer. Further, immune cell-related signatures differed significantly between prognostically favorable and unfavorable clusters. Further research is necessary to explore potential diagnostic and therapeutic implications.  \nKeywords Prostate cancer · Radiomics · DNA methylation-based tumor deconvolution  \nAbbreviations  \nADC Apparent diffusion coefficient  \nBPH Benign prostatic hyperplasia  \nDCE Dynamic contrast-enhanced  \nDICOM Digital imaging and communications in medicine  \nESUR European society of urogenital radiology HoLEP Holmium laser enucleation of the prostate ISUP International society of urological pathology  \nLUMP Leucocytes unmethylation for purity mpMRI Multiparametric magnetic resonance imaging PCa Prostate cancer  \nExtended author information available on the last page of the article  \nPI-RADS Prostate imaging reporting and data system  \nRPX Radical prostatectomy  \nT2w T2-weighted  \nVOI Volume of interest  \nIntroduction  \nProstate cancer (PCa) is the second most common cancer in men (Sung et al. 2021) . Advances in multiparametric MRI (mpMRI) improved patient management and biopsy techniques (Mottet et al. 2019) . Yet, tumor heterogeneity can  \ncompromise pathologic confirmation of diagnosis (Stewart et al. 2013; Guo et al. 2018) . The comprehensive molecular characterization of PCa is the basis for effective biomarker development (Guo et al. 2018) . However, biopsies not only sample tumor cells but also the adjacent tumor microenvironment, which impacts genomic analysis and interpretation of results (Aran et al. 2015) . Here, epigenetic analyses can be a way forward. For example, leucocytes unmethylation for purity (LUMP) measures the im","cbCaikYwf4WQaAox","https://ap.wps.com/l/cbCaikYwf4WQaAox","pdf",1825206,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Materials and methods","[{\"question\":\"What is the study purpose regarding epigenetic profiling in prostate cancer?\",\"answer\":\"To discover biomarkers using DNA methylation-based deconvolution in benign versus malignant prostate tissue and to assess whether radiomics can act as a non-invasive surrogate for epigenetic signatures.\"},{\"question\":\"How were patients selected and what imaging was used?\",\"answer\":\"Thirty prostate cancer patients were retrospectively included, all having multiparametric MRI prior to radical prostatectomy between 2014 and 2019. Control tissue came from benign tissue adjacent to tumor lesions and from benign prostatic hyperplasia.\"},{\"question\":\"What were the key findings about latent methylation components and radiomics performance?\",\"answer\":\"Latent methylation components formed two clusters with prognostic impact; one cluster aligned with malignant tissue and reduced immune-cell-related signatures. No radiomics model could non-invasively predict the epigenetic clusters.\"}]","Epigenetic profiling of prostate cancer reveals potential prognostic signatures | PDF",1790016028,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc736ab6ee48e34e492885e5c49e2c62.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92db03f626cdbc8d2625222cdb16970c.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f1fae77a66ce57ab2eb2f647154dd12.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e713ea651f6f9226e3f17e9a3d05bdaf.webp",980,1301]